#China’s vaccine, the CanSino candidate, is one of a handful of vaccines that have shown some promise in early human testing. The phase 1 and 2 trial results from a vaccine developed by researchers at the University of Oxford and British-Swedish company AstraZeneca were also released on Monday. How will this vaccine be rolled out in practice?
Guests:
Eric Ding
Senior Fellow, Federation of American Scientists
Dr Wu Zhiwei
Medical School of Nanjing University
Subscribe to us on YouTube:
Download our APP on Apple Store (iOS):
Download our APP on Google Play (Android):
Follow us on:
Website:
Facebook:
Twitter:
Instagram:
Pinterest:
Weibo:
Douyin:
